Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
PHOTO ESSAY: Summer camp for kids with autoimmune diseases - 2Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
- 3UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- 4Gym tied to outbreak of obscure disease that spreads through mist
- 55 Chiefs That Changed Our Opinion on Film
- 5 Must-Attempt Outlandish Dishes from Around the World
- Remain Fit and Sound with These Exercise Fundamentals
- Top Breakfast Food: What's Your Morning Pleasure?
- Grasping Various Kinds of Local misdemeanors
- Council removes proposal to rename park named after former president of Israel
- This Week In Space podcast: Episode 188 — A New NASA Leader Rises?
- Step by step instructions to Analyze Senior Insurance Contracts Really.
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- At least 36 dead in major fire in Hong Kong residential blocks
